K&L, which provides end-to-end services for all types of clinical studies, said it is planning to expand its capabilities in the US, Asia and the Pacific region, especially in China.
OpenClinica chief operating officer Ben Baumann said, "We welcome this opportunity to work closely with K&L to help them grow their global practice."
K&L Consulting Services biostatistics and data management vice president Henry Wu said, "OpenClinica Enterprise allows us to deploy studies quickly and cost effectively, and pass this value on to our clients."
In addition to OpenClinica Enterprise Edition, OpenClinica’s products include OpenClinica Community Edition, which is freely available under a common open source license.